This content is in French.
Ozenoxacin: the new weapon against impetigo
12 août 2025
By Ana Espino | Published on August 12, 2025 | 3 min read
Impetigo is a highly contagious bacterial skin infection, common in pediatrics but also affecting adults, particularly in situations of close contact or when the skin barrier is compromised. It most often presents as erythematous lesions covered with honey-colored crusts, located on the face, hands, or other exposed areas, and may be bullous or non-bullous. This condition is mainly caused by Staphylococcus aureus — including methicillin-resistant strains (MRSA) — and Streptococcus pyogenes. Beyond the physical discomfort and cosmetic concerns, impetigo has a notable psychosocial impact and contributes to rapid community transmission, particularly in school or family settings.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Tuesta, B. L., et al. (2025). Ozenoxacin 1% in Pediatric and Adult Patients with Impetigo: A Meta-Analysis of Randomized Trials. Journal of clinical medicine, 14(7), 2157
View the source
